Arena Pharmaceuticals, Inc. (ARNA) Posts Q2 Loss of 12c/Share, Wider than Views

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q2 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $22 million versus the consensus estimate of $7.38 million.

For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c